Combined-modality therapy for unresectable, stage III non-small-cell lung cancer - Caveat emptor or caveat venditor?

被引：8

|

作者：

Johnson, DH

机构：

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1996年 / 88卷 / 17期

关键词：

D O I：

10.1093/jnci/88.17.1175

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1175 / 1177

页数：3

相关论文

共 50 条

[1] Combined-modality therapy for unresectable, stage III non-small-cell lung cancer - Caveat emptor or caveat venditor?
Hayman, JA
Lichter, AS
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (24) : 1866 - 1866
[2] The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly
Schild, SE
Stella, PJ
Geyer, SM
Bonner, JA
McGinnis, WL
Mailliard, JA
Brindle, J
Jatoi, A
Jett, JR
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) : 3201 - 3206
[3] Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: A review of the current literature and recommendations for treatment
Bayman, Neil A.
Blackhall, Fiona
Jain, Pooja
Lee, Lip
Thatcher, Nick
Faivre-Finn, Corinne
[J]. CLINICAL LUNG CANCER, 2008, 9 (02) : 92 - 101
[4] Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor
Hermanson, Terhi T. O.
Hrushesky, William J.
Knopf, Kevin B.
Bennett, Charles L.
[J]. JOURNAL OF ONCOLOGY PRACTICE, 2015, 11 (05) : 363 - +
[5] Combined Modality Therapy for Stage III Non-Small-Cell Lung Cancer
Anderson, Cynthia S.
Curran, Walter J.
[J]. SEMINARS IN RADIATION ONCOLOGY, 2010, 20 (03) : 186 - 191
[6] Outcome of combined-modality treatment for stage IIIA non-small-cell lung cancer
ElSayed, S
Paprocki, I
Mihalciou, C
Chowdhury, A
Leylek, A
Unruh, H
[J]. RADIOLOGY, 1996, 201 : 1498 - 1498
[7] The Evaluation of Radiation Therapy and Combined-modality Therapy for Non-small-cell Lung Cancer in Elderly
Yoon, Won-Sup
Yang, Dae-Sik
Kim, Chul-Yong
[J]. RADIATION ONCOLOGY JOURNAL, 2007, 25 (02): : 101 - 108
[8] SEQUENTIAL COMBINED MODALITY THERAPY FOR STAGE-III NON-SMALL-CELL LUNG-CANCER
VOKES, EE
[J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (06) : 1133 - 1142
[9] Stage IIIA N2 non-small-cell lung cancer: current controversies in combined-modality therapy
Thomas, Pascal Alexandre
[J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 36 (03) : 431 - 432
[10] Cost of combined modality interventions for stage III non-small-cell lung cancer
Evans, WK
Will, P
Berthelot, JM
Earle, CC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (09) : 3038 - 3048

← 1 2 3 4 5 →